Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection. - Vibholm L; Schleimann MH; Højen JF; Benfield T; Offersen R; Rasmussen K; Olesen R; Dige A; Agnholt J; Grau J; Buzon M; Wittig B; et al. (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017)